On (b)(6) 2014, baxter (b)(4) was informed of an event that occurred at the (b)(6).The event involved the baxter em2400 exactamix compounder, using abacus® software.The exactamix compounder is an automated pumping system that compounds multiple sterile ingredients into a finished solution, and is designed for the preparation of total parenteral nutrition (tpn) solutions.The customer stated that after a tpn order had been created and administered to a patient, they realized that the osmolarity level of the solution was higher than expected.The customer did not report any adverse effects to the patient.Baxter technical support assisted the customer in checking their abacus software warning limit settings and discovered that the customer had not created a limit setting for pediatric patients >/= 40kg.Tech support instructed the customer in how to set the warning limits needed.We are submitting this mdr because the baxter (b)(4) manager of medical affairs stated that, if the patient were to receive a hyperosmolar solution, phlebitis can occur.If the phlebitis progresses to a thrombophlebitis, though improbable, this could lead to an adverse patient event including potential patient death.
|